I didn’t see a diary on this but here is a good example of what Romney’s plans for streamlining regulations is about.
Craig Unger has an article up at Salon about how Mitt Romney played a key role in the current meningitis outbreak. An outbreak that has infected at least 344 people of which 25 have died so far.
The fatal meningitis epidemic sweeping the United States can now be traced to the failure of then-Gov. Mitt Romney to adequately regulate the Massachusetts pharmaceutical company that is being blamed for the deaths.
Today’s problems are not the first for this company. Turns out it has a decade long history of complaints and problems.
Massachusetts state records revealed that between 2003 and 2006, there were six complaints regarding NECC and its co-owner, Barry Cadden. At least one of these complaints alleged that NECC’s methylprednisolone acetate failed to comply with pharmaceutical standards. This is the same drug involved in the current epidemic.
Romney’s solution was to let NECC monitor itself least official sanctions and investigations might harm their business profits.
in a letter dated Nov. 11, 2004, Paul Cirel, an attorney for NECC, argued that such disciplinary action would be “potentially fatal” to NECC’s business. In a footnote, he asserted, “Once disclosed, the reprimand will surely result in investigations/inquiries/investigations in those other jurisdictions. Regardless of the derivative actions taken, the attendant legal and administrative costs will be devastating.”
....
Subsequently, in 2006, NECC was effectively permitted to monitor itself simply by assuring the board it was in compliance with all procedures
.
Please read this article and note at the bottom
NEC president Greg Coniglario hosted a fundraiser for Sen. Scott Brown, bringing in $37,000 for the Brown campaign against Elizabeth Warren. Conigliaro and members of his family have reportedly given $10,000 of their own money to Brown.
Brown returned the favor by signing
a letter to the Drug Enforcement Agency arguing that regulations on the compounding industry should be loosened
.